Bill > HR4307

This bill, the Medical Supply Chain Resiliency Act, aims to improve the resilience of the United States' medical supply chain by authorizing the President to enter into trade agreements with trusted partner countries. The key provisions of the bill include: 1. Allowing the President to negotiate and enter into "trusted trade partner agreements" with countries that demonstrate a commitment to maintaining open trade in medical goods during public health emergencies, adhere to intellectual property rights protections, and adopt good regulatory practices. These agreements can reduce or eliminate trade barriers, diversify supplier networks, harmonize regulatory procedures, and promote collaboration on research and development. 2. Requiring the President to provide notice to and consult with Congress before negotiating and entering into these agreements, and allowing Congress to review and potentially disapprove of the agreements. 3. Requiring the U.S. Trade Representative to monitor the compliance of trusted trade partners with their commitments under the agreements and authorizing the President to take actions, such as suspending the agreements, if a partner fails to comply. The overall goal of the bill is to strengthen the resilience of the U.S. medical supply chain, especially in the face of future public health emergencies, by diversifying trade relationships and ensuring a reliable supply of critical medical goods.